Editors' note: ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In “ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS,” Crockford et al. presented data that show that patients with ALS have impaired cognition and behavior and that these deficits worsen with increasing severity of disease. Raaphorst et al. question whether these changes are the result of frontotemporal dementia or nocturnal hypoventilation due to ALS-associated respiratory muscle weakness. They suggest that it would be helpful to have data on the number of stage 4 patients (patients with respiratory or nutritional insufficiency requiring intervention) who required noninvasive ventilation (NIV) and the extent of each subject's respiratory dysfunction. Abrahams and Crockford reply that 27.78% of stage 4 patients required NIV, but that there was no significant difference in cognition or behavior and requirement for NIV or lack thereof. However, they agree with Raaphorst et al. that given that respiratory dysfunction is a feature of late-stage ALS and memory impairment is associated with advanced-stage ALS, ventilatory support could potentially improve memory deficits in this population. They emphasize that further research on the relationship between respiratory dysfunction and cognition/behavior in ALS is required, as the current data on this topic come from a single small study.
In “ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS,” Crockford et al. presented data that show that patients with ALS have impaired cognition and behavior and that these deficits worsen with increasing severity of disease. Raaphorst et al. question whether these changes are the result of frontotemporal dementia or nocturnal hypoventilation due to ALS-associated respiratory muscle weakness. They suggest that it would be helpful to have data on the number of stage 4 patients (patients with respiratory or nutritional insufficiency requiring intervention) who required noninvasive ventilation (NIV) and the extent of each subject's respiratory dysfunction.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
Dr. Kathleen Digre and Dr. Kendra Pham
► Watch
Related Articles
Alert Me
Recommended articles
-
Special Article
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review)Report of the Quality Standards Subcommittee of the American Academy of NeurologyR. G. Miller, C. E. Jackson, E. J. Kasarskis et al.Neurology, October 12, 2009 -
Article
Variation in noninvasive ventilation use in amyotrophic lateral sclerosisNimish J. Thakore, Brittany R. Lapin, Erik P. Pioro et al.Neurology, June 10, 2019 -
Corrections
TDP43 pathology in the brain, spinal cord, and dorsal root ganglia of a patient with FOSMNet al.Neurology, July 08, 2019 -
Corrections
Journal Club: Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhageset al.Neurology, July 08, 2019